Blinded, Randomized Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline Biologicals' Measles-mumps-rubella-varicella Candidate Vaccine Given to Healthy Children During the Second Year of Life
Phase of Trial: Phase III
Latest Information Update: 30 Sep 2016
At a glance
- Drugs MMR-varicella zoster virus vaccine (Primary) ; Measles mumps and rubella virus vaccine-(Priorix)
- Indications Chickenpox; Measles; Mumps; Rubella
- Focus Pharmacodynamics; Registrational
- Sponsors GlaxoSmithKline
- 05 Jul 2007 Status changed from in progress to completed.
- 17 Jul 2006 Status changed from initiated to in progress
- 05 Nov 2005 New trial record.